BR112014007177A2 - agente antifúngico - Google Patents

agente antifúngico

Info

Publication number
BR112014007177A2
BR112014007177A2 BR112014007177A BR112014007177A BR112014007177A2 BR 112014007177 A2 BR112014007177 A2 BR 112014007177A2 BR 112014007177 A BR112014007177 A BR 112014007177A BR 112014007177 A BR112014007177 A BR 112014007177A BR 112014007177 A2 BR112014007177 A2 BR 112014007177A2
Authority
BR
Brazil
Prior art keywords
antifungal agent
scytalidium
fungus
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
BR112014007177A
Other languages
English (en)
Inventor
Koga Hiroyasu
Tsuboi Ryoji
Nanjoh Yasuko
Original Assignee
Nihon Nohyaku Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Nohyaku Co Ltd filed Critical Nihon Nohyaku Co Ltd
Publication of BR112014007177A2 publication Critical patent/BR112014007177A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02—Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Abstract

resumo patente de invenção: "agente antifúngico". a presente invenção refere-se a um agente antifúngico contra um fungo do gênero scytalidium (scytalidium dimidiatum, scytalidium hyalinum, etc.), de preferência, um agente antifúngico para as micoses superficiais causadas por um fungo do gênero scytalidium como um fungo patogênico, que contém luliconazol ou um sal farmaceuticamente aceitável dos mesmos e/ou lanoconazol ou um sal farmaceuticamente aceitável dos mesmos como ingrediente(s) ativo(s). 20849133v1
BR112014007177A 2011-09-26 2012-09-25 agente antifúngico BR112014007177A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011209903 2011-09-26
PCT/JP2012/074580 WO2013047530A1 (ja) 2011-09-26 2012-09-25 抗真菌剤

Publications (1)

Publication Number Publication Date
BR112014007177A2 true BR112014007177A2 (pt) 2017-04-04

Family

ID=47995562

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014007177A BR112014007177A2 (pt) 2011-09-26 2012-09-25 agente antifúngico

Country Status (8)

Country Link
US (1) US9040573B2 (pt)
EP (1) EP2762139B1 (pt)
JP (1) JP5349716B2 (pt)
CN (1) CN103957907B (pt)
BR (1) BR112014007177A2 (pt)
ES (1) ES2580480T3 (pt)
MX (1) MX339306B (pt)
WO (1) WO2013047530A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3071200A1 (en) * 2013-11-19 2016-09-28 Pola Pharma Inc. Pharmaceutical composition for treatment of pneumonia associated with fusarium fungus
WO2015156219A1 (ja) * 2014-04-07 2015-10-15 日本農薬株式会社 抗真菌剤とステロイドとを含有する医薬組成物
ITUB20155902A1 (it) 2015-11-25 2017-05-25 Nathura S P A Composizione farmaceutica cicatrizzante per uso topico
CN105541813B (zh) * 2016-02-29 2019-05-10 浙江东亚药业股份有限公司 一种咪唑乙腈衍生物酸式盐及其制备方法和应用
CN107865825B (zh) * 2016-09-28 2022-05-20 四川海思科制药有限公司 一种卢立康唑外用喷雾剂药物组合物及其制备方法
CN112957319A (zh) * 2021-02-05 2021-06-15 王京海 一种抗真菌液及其制备方法和应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6293227A (ja) 1985-10-19 1987-04-28 Nippon Nohyaku Co Ltd 抗真菌剤
JP3278738B2 (ja) 1995-07-08 2002-04-30 日本農薬株式会社 抗真菌剤
RU2415669C2 (ru) * 2006-03-08 2011-04-10 Нихон Нохияку Ко., Лтд. Фармацевтическая композиция для наружного применения
HUE029707T2 (en) 2007-08-27 2017-03-28 Nihon Nohyaku Co Ltd Anti-fungal dermatitis
JP2011209903A (ja) 2010-03-29 2011-10-20 Sony Corp 命令フェッチ装置、プロセッサ、プログラム変換装置、および、プログラム変換方法

Also Published As

Publication number Publication date
CN103957907B (zh) 2016-03-30
CN103957907A (zh) 2014-07-30
EP2762139A1 (en) 2014-08-06
ES2580480T3 (es) 2016-08-24
US9040573B2 (en) 2015-05-26
MX339306B (es) 2016-05-18
JPWO2013047530A1 (ja) 2015-03-26
MX2014003563A (es) 2014-11-26
EP2762139A4 (en) 2015-03-18
US20140142154A1 (en) 2014-05-22
JP5349716B2 (ja) 2013-11-20
EP2762139B1 (en) 2016-04-13
WO2013047530A1 (ja) 2013-04-04

Similar Documents

Publication Publication Date Title
CO2017001493A2 (es) Kits que comprenden inhibidores tigit y agentes anticáncer
BR112014025711A2 (pt) composto, medicamento, e, uso de um composto
BR112014007177A2 (pt) agente antifúngico
BR112015022972A2 (pt) composição farmacêutica de cloridrato de s-cetamina
BR112015010663A2 (pt) formas de dosagem de ruxolitinib de liberação sustentada
PE20160052A1 (es) Composicion farmaceutica de clorhidrato de s-cetamina
GT201200276A (es) Combinaciones de compuestos activos
BR112014023379A8 (pt) Microemulsões com base em ciclodextrina e usos dermatológicos das mesmas
UY34997A (es) Agente de control de endoparásitos y método para usarlo
MX2019003906A (es) Composiciones parasiticidas que comprenden un agente activo de isoxazolina, sus metodos y usos.
BR112015000704A2 (pt) imidazotriazinacarbonitrilas úteis como inibidores de quinase
MX2015004644A (es) Compuestos de carbohidratos con funcion de galactosa para el tratamiento de la nefropatia diabetica y de los trastornos asociados.
BR112014007257A2 (pt) composto, medicamento, métodos para inibir um colesterol 24-hidrolase em um mamífero e para a profilaxia ou tratamento de doença neurodegenerativa em um mamífero, e, uso do composto ou sal
CO6821938A2 (es) Un compuesto de guanidina o una sal del mismo para el tratamiento de enfermedades relacionadas con vap -1
CL2014003225A1 (es) Composición que comprende un agente de control biológico y un fungicida.
NI201100025A (es) Métodos de administración de las formulaciones tópicas antimicóticas para el tratamiento de las infecciones por hongos.
PE20140255A1 (es) Tableta dispersable en forma oral
CR20140005A (es) Una nueva composición terapéutica que contiene apomorfina como principio activo
AR085616A1 (es) Composicion farmaceutica inhalable que comprende glicopirrolato, uso
RS53783B1 (en) INHALATION MEDICINAL PRODUCTS INCLUDING TIOTROPIUM
BR112013018938A8 (pt) composto antifúngico tópico, agente antifúngico para tinha e agente antitinha das unhas.
BR112014017902A2 (pt) Agente terapêutico ou profilático para doenças causadas por distúrbios do metabolismo de glicose
CR10524A (es) Compuesto triciclico y uso farmaceutico del mismo
RU2013110517A (ru) Средство для профилактики или лечения неалкогольного стеатогепатита
BR112015019524A2 (pt) tratamento de combinação

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B06T Formal requirements before examination [chapter 6.20 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL